Is 89bio Stock a Good Investment?
89bio Investment Advice | ETNB |
- Examine 89bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research 89bio's leadership team and their track record. Good management can help 89bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact 89bio's business and its evolving consumer preferences.
- Compare 89bio's performance and market position to its competitors. Analyze how 89bio is positioned in terms of product offerings, innovation, and market share.
- Check if 89bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about 89bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in 89bio Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if 89bio Inc is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine 89bio Stock
Researching 89bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 94.0% of the company shares are held by institutions such as insurance companies. The book value of 89bio was currently reported as 3.34. The company recorded a loss per share of 3.51. 89bio Inc had not issued any dividends in recent years.
To determine if 89bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding 89bio's research are outlined below:
| 89bio Inc had very high historical volatility over the last 90 days | |
| Net Loss for the year was (367.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 89bio Inc currently holds about 193.34 M in cash with (367.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.16. | |
| 89bio Inc has a frail financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Disposition of 1050 shares by Le-nguyen Quoc of 89bio at 10.57 subject to Rule 16b-3 |
89bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in 89bio Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to 89bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact 89bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises 89bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.46 | -0.54 | -0.08 | 17 | ||
2023-11-08 | 2023-09-30 | -0.53 | -0.45 | 0.08 | 15 | ||
2024-08-05 | 2024-06-30 | -0.57 | -0.48 | 0.09 | 15 | ||
2020-05-13 | 2020-03-31 | -0.86 | -0.76 | 0.1 | 11 | ||
2023-08-09 | 2023-06-30 | -0.41 | -0.52 | -0.11 | 26 | ||
2022-08-11 | 2022-06-30 | -1.05 | -1.23 | -0.18 | 17 | ||
2021-08-12 | 2021-06-30 | -0.84 | -1.03 | -0.19 | 22 | ||
2023-03-10 | 2022-12-31 | -0.69 | -0.48 | 0.21 | 30 |
89bio Target Price Consensus
89bio target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. 89bio's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most 89bio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand 89bio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of 89bio Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure Valuation89bio Target Price Projection
89bio's current and average target prices are 8.79 and 30.12, respectively. The current price of 89bio is the price at which 89bio Inc is currently trading. On the other hand, 89bio's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On 89bio Target Price
89bio Analyst Ratings
89bio's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about 89bio stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of 89bio's financials, market performance, and future outlook by experienced professionals. 89bio's historical ratings below, therefore, can serve as a valuable tool for investors.Know 89bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as 89bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 89bio Inc backward and forwards among themselves. 89bio's institutional investor refers to the entity that pools money to purchase 89bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Pictet Asset Manangement Sa | 2024-12-31 | 3 M | State Street Corp | 2024-12-31 | 2.9 M | Geode Capital Management, Llc | 2024-12-31 | 2.2 M | Redmile Group, Llc | 2024-12-31 | 2.2 M | Candriam Luxembourg S.c.a. | 2024-12-31 | 1.1 M | Alliancebernstein L.p. | 2024-12-31 | 1 M | Balyasny Asset Management Llc | 2024-12-31 | 1 M | Integral Health Asset Management, Llc | 2024-12-31 | 1000 K | Alyeska Investment Group, L.p. | 2024-12-31 | 925.4 K | Hhg Plc | 2024-12-31 | 16.5 M | Ra Capital Management, Llc | 2024-12-31 | 14.2 M |
89bio's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.27 B.Market Cap |
|
89bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.77) | (0.81) | |
| Return On Capital Employed | (0.87) | (0.91) | |
| Return On Assets | (0.77) | (0.81) | |
| Return On Equity | (0.92) | (0.87) |
Determining 89bio's profitability involves analyzing its financial statements and using various financial metrics to determine if 89bio is a good buy. For example, gross profit margin measures 89bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of 89bio's profitability and make more informed investment decisions.
Please note, the presentation of 89bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, 89bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of 89bio's management manipulating its earnings.
Evaluate 89bio's management efficiency
89bio Inc has return on total asset (ROA) of (0.4473) % which means that it has lost $0.4473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7834) %, meaning that it created substantial loss on money invested by shareholders. 89bio's management efficiency ratios could be used to measure how well 89bio manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -0.81. In addition to that, Return On Capital Employed is expected to decline to -0.91. The current year's Other Current Assets is expected to grow to about 38.3 M, whereas Total Assets are forecasted to decline to about 275.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.83 | 4.52 | |
| Tangible Book Value Per Share | 3.83 | 4.52 | |
| Enterprise Value Over EBITDA | (1.81) | (1.90) | |
| Price Book Value Ratio | 2.04 | 2.15 | |
| Enterprise Value Multiple | (1.81) | (1.90) | |
| Price Fair Value | 2.04 | 2.15 | |
| Enterprise Value | 625.2 M | 656.4 M |
Leadership effectiveness at 89bio Inc is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 1.341 |
Basic technical analysis of 89bio Stock
As of the 20th of March, 89bio shows the Mean Deviation of 3.82, market risk adjusted performance of 0.1516, and Coefficient Of Variation of 2253.03. 89bio Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.89bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 89bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on 89bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 89bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
89bio's Outstanding Corporate Bonds
89bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 89bio Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 89bio bonds can be classified according to their maturity, which is the date when 89bio Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand 89bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing 89bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0476 | |||
| Market Risk Adjusted Performance | 0.1516 | |||
| Mean Deviation | 3.82 | |||
| Semi Deviation | 4.11 | |||
| Downside Deviation | 4.25 | |||
| Coefficient Of Variation | 2253.03 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.75 | |||
| Information Ratio | 0.0593 | |||
| Jensen Alpha | 0.4175 | |||
| Total Risk Alpha | 0.8874 | |||
| Sortino Ratio | 0.0811 | |||
| Treynor Ratio | 0.1416 | |||
| Maximum Drawdown | 35.21 | |||
| Value At Risk | (8.41) | |||
| Potential Upside | 10.74 | |||
| Downside Variance | 18.09 | |||
| Semi Variance | 16.87 | |||
| Expected Short fall | (4.75) | |||
| Skewness | 1.7 | |||
| Kurtosis | 5.96 |
| Risk Adjusted Performance | 0.0476 | |||
| Market Risk Adjusted Performance | 0.1516 | |||
| Mean Deviation | 3.82 | |||
| Semi Deviation | 4.11 | |||
| Downside Deviation | 4.25 | |||
| Coefficient Of Variation | 2253.03 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.75 | |||
| Information Ratio | 0.0593 | |||
| Jensen Alpha | 0.4175 | |||
| Total Risk Alpha | 0.8874 | |||
| Sortino Ratio | 0.0811 | |||
| Treynor Ratio | 0.1416 | |||
| Maximum Drawdown | 35.21 | |||
| Value At Risk | (8.41) | |||
| Potential Upside | 10.74 | |||
| Downside Variance | 18.09 | |||
| Semi Variance | 16.87 | |||
| Expected Short fall | (4.75) | |||
| Skewness | 1.7 | |||
| Kurtosis | 5.96 |
Consider 89bio's intraday indicators
89bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 89bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
89bio Corporate Filings
| 3rd of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 19th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify |
89bio Stock media impact
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.
89bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
89bio Corporate Management
| Harry MD | Chief Officer | Profile | |
| Francis Sarena | Chief Officer | Profile | |
| Rohan Palekar | CEO Director | Profile | |
| Quoc LeNguyen | Chief Quality | Profile | |
| Shiva CPA | Senior Officer | Profile | |
| Shiva Natarajan | Senior Officer | Profile | |
| Amanda Hill | VP Culture | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between 89bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.